Back to Directory

Rhonda White

Email

rwhite@fhi360.org

Phone

919-321-3598

Institution

FHI 360

Title

Senior Community Program Associate

Address

FHI 360
359 Blackwell Street
Suite 200
Durham, NC 27701
USA

Request an Update

Affiliated Studies

IMPAACT 2044: Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy

DAIDS Number

Research Area

Study Status

IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children

DAIDS Number

Research Area

Study Status

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2015: Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults with Cognitive Impairment

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status